Cinepazide

This classification denotes a vasodilating agent with the molecular formula C22H31N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67Y4P5C84X, chemically known as 1-((1-pyrrolidinylcarbonyl)methyl)-4-(3,4,5-trimethoxycinnamoyl)piperazine but generally known as cinepazide, which bears US NIH Compound Identifier 2759. European Medicines Agency schedules Cinepazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06293MIG. The term CINEPAZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules cinepazide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule cinepazide under HS 29335995 and SITC 51576. As of Q4 2014, CINEPAZIDE remains the US FDA Preferred Term for this commodity. Cinepazide bears US NLM identifiers UMLS ID C0055740 and NCI Concept Code C91001. SMILES: O=C(N1CCCC1)CN1CCN(CC1)C(=O)/C=C/c1cc(OC)c(OC)c(OC)c1.